top
Search terms
Results 1 - 7 of 7 - ordered by :
Ehjcvp

[...]of progress made in HFREF therapy, cumulative mortality benefit amounts to almost a three-fold decrease in death rate whether in severe or in mild-to-moderate HFREF. In chronic HEFREF, it is ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIALS, Faiez Zannad

Date : 01/01/2015 Item size : 180641 bytes
Ehjcvp

Optimization of heart failure medication after cardiac resynchronization therapy and the impact on long-term survival Abstract Aims Treatment with evidence-based heart failure (HF) medication ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLE, Christoffer Tobias Witt, Mads Brix Kronborg, Ellen Aagaard Nohr, Peter Thomas Mortensen, Christian Gerdes, Jens Cosedis ...

Date : 01/07/2015 Item size : 273569 bytes
Ehjcvp

In this issue of the journal, Jørgensen and co-workers report temporal changes in patient characteristics and pharmacotherapy in 156 496 patients referred for coronary angiography between 2000 and ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIALS, Stefan Agewall

Date : 01/07/2015 Item size : 94363 bytes
Ehjcvp

The EMPA-REG outcome trial showed improved survival and less hospitalization for HF: it is changing concepts and practice.1 The new era of outcome trials follows the acute awareness of the need to ...

European Heart Journal - Cardiovascular Pharmacotherapy, Editorials, Basil S. Lewis

Date : 01/10/2016 Item size : 203582 bytes
Ehjcvp

Thanks to these investigations, European and American scientific societies have developed guidelines that provide evidence-based recommendations for treating acute and chronic HF,1,2 including ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIAL, Francesco Pelliccia, Giuseppe M.C. Rosano

Date : 01/01/2015 Item size : 131344 bytes
Ehjcvp

The HFA Congress hosted the release of the new HFA/ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and these guidelines have been the key theme of the congress.1 ...

European Heart Journal - Cardiovascular Pharmacotherapy, Editorials, Giuseppe M.C. Rosano

Date : 01/01/2017 Item size : 111355 bytes
Ehjcvp

[...]the three pivotal clinical trials investigating the use of beta-blockers in HF (CIBIS II, COPERNICUS, and MERIT-HF) showed an approximate 34% relative reduction in mortality.13 ACE inhibitors ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIAL, Massimo Volpe, Pietro Francia

Date : 01/07/2015